CN115700269A - Organic electroluminescent composition and application thereof - Google Patents

Organic electroluminescent composition and application thereof Download PDF

Info

Publication number
CN115700269A
CN115700269A CN202110875588.5A CN202110875588A CN115700269A CN 115700269 A CN115700269 A CN 115700269A CN 202110875588 A CN202110875588 A CN 202110875588A CN 115700269 A CN115700269 A CN 115700269A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
phenyl
carbazolyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110875588.5A
Other languages
Chinese (zh)
Inventor
李祥智
蔡烨
魏定纬
丁欢达
陈志宽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Lumilan Advanced Materials Co Ltd
Original Assignee
Ningbo Lumilan Advanced Materials Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo Lumilan Advanced Materials Co Ltd filed Critical Ningbo Lumilan Advanced Materials Co Ltd
Priority to CN202110875588.5A priority Critical patent/CN115700269A/en
Publication of CN115700269A publication Critical patent/CN115700269A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Electroluminescent Light Sources (AREA)

Abstract

The invention provides an organic electroluminescent composition and application thereof, wherein the organic electroluminescent composition comprises a fused heterocyclic compound containing a quinazoline structure and a hole transport type compound, and the fused heterocyclic compound containing the quinazoline structure is a compound with a structure shown as a formula (1-1) or a formula (1-2). The organic electroluminescent composition can enable an OLED device to have lower driving voltage, higher current efficiency and longer service life.

Description

Organic electroluminescent composition and application thereof
Technical Field
The invention belongs to the technical field of organic electroluminescence, and relates to an organic electroluminescent composition and application thereof.
Background
An Electroluminescent (EL) device is a self-luminous device, which is advantageous in that it provides a wide viewing angle, a large contrast ratio, and a fast response time.
The most important factor determining the luminous efficiency of an organic EL device is a light emitting material. Heretofore, fluorescent materials have been widely used as light emitting materials. However, in view of the electroluminescent mechanism, since phosphorescent materials theoretically enhance the luminous efficiency four (4) times as compared to fluorescent materials, phosphorescent light-emitting materials are being widely studied. Iridium (III) complexes have been widely referred to as phosphorescent materials. Currently, 4'-N, N' -dicarbazole-biphenyl (CBP) is the most well known host material for phosphorescent materials. But it has the following disadvantages: (1) Due to its low glass transition temperature and poor thermal stability, it may degrade in vacuum during high temperature deposition processes. (2) The power efficiency of the organic EL device is given by [ (pi/voltage) × current efficiency ], and the power efficiency is inversely proportional to the voltage. Although organic EL devices including phosphorescent host materials provide higher current efficiency (cd/a) than organic EL devices including fluorescent materials, significantly high driving voltages are necessary. Therefore, there is no advantage in terms of power efficiency (1 m/W). (3) Further, the organic EL device has a short lifetime, and improvement in luminous efficiency is still required. In order to solve the problem of the aforementioned phosphorescent material, it has been attempted to form a light-emitting layer having two or more host compounds.
WO2011/136755 and WO2013/146645 disclose organic electroluminescent devices in which the light-emitting layer comprises two or more host compounds including indolocarbazole-based compounds. However, the luminous efficiency, lifetime, and the like of the indolocarbazole compounds disclosed in the references are to be further improved.
Disclosure of Invention
In view of the defects of the prior art, the invention aims to provide an organic electroluminescent composition and application thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
in one aspect, the invention provides an organic electroluminescent composition, which comprises a fused heterocyclic compound containing a quinazoline structure and a hole transport type compound, wherein the fused heterocyclic compound containing the quinazoline structure is a compound having a structure shown as a formula (1-1) or a formula (1-2),
Figure BDA0003190395170000011
l is selected from a linkage, a substituted or unsubstituted C6-C30 arylene, a substituted or unsubstituted C5-C30 heteroarylene,
ar is selected from substituted or unsubstituted C6-C60 aryl, substituted or unsubstituted C5-C60 heteroaryl, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C6-C60 arylamine, substituted or unsubstituted C5-C60 heteroarylamine and substituted or unsubstituted C5-C60 arylheteroarylamine,
R 1 -R 3 each independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxy, or substituted or unsubstituted C6-C30 aryloxy,
R n1 -R n8 、R m1 -R m6 each independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxy, or substituted or unsubstituted C6-C30 aryloxy.
In the invention, through the matching of the fused heterocyclic compound containing the quinazoline structure and the hole-transport compound, the combination of electrons and holes is stronger, which is more beneficial to the improvement of luminous efficiency and the prolonging of the service life of devices.
Preferably, ar is selected from the following carbazole groups:
Figure BDA0003190395170000021
R 4 -R 11 each independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, C1-C30 alkyl wherein one or more methylene groups are substituted by-O-or-S-in such a way that the O atom or S atom is not adjacent, substituted or unsubstitutedC2-C30 alkenyl, C2-C30 alkenyl in which one or more methylene groups are replaced by-O-or-S-in such a way that O atoms or S atoms are not adjacent, substituted or unsubstituted C2-C30 alkynyl, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxy, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C6-C60 arylamino, substituted or unsubstituted C5-C60 heteroarylamino, substituted or unsubstituted C5-C60 arylheteroaryl, R arylamino 4 -R 11 Each independently exists or the two adjacent exist and are connected to form a ring A; and/or R 4 And R 11 Through a benzene ring or a naphthalene ring;
preferably, the ring a is a substituted or unsubstituted benzene ring, a substituted or unsubstituted naphthalene ring, a substituted or unsubstituted benzothiophene ring, a substituted or unsubstituted benzofuran ring, a substituted or unsubstituted indene ring, a substituted or unsubstituted indole ring, a substituted or unsubstituted benzindole ring, a substituted or unsubstituted naphthoindole ring;
preferably, R 4 -R 11 Any two adjacent of them are fused with benzene ring, and/or R 4 And R 11 Through benzene ring or naphthalene ring;
preferably, R 4 -R 11 Each independently selected from the group consisting of substituted or unsubstituted: phenyl, carbazolyl, phenyl-substituted carbazolyl, biphenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, dibenzofuran-substituted carbazolyl, terphenyl-substituted carbazolyl;
preferably, R 4 -R 11 Either one of them is combined with
Figure BDA0003190395170000022
The connection is carried out by connecting the two parts,
L 1 selected from the group consisting of a linking bond, phenylene, naphthylene, biphenylene,
Ar 1 、Ar 2 each independently selected from substituted or unsubstitutedThe following groups: phenyl, biphenyl, terphenyl, naphthyl, pyridyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, dibenzofuranyl, dibenzothiophenyl, dimethylfluorenyl, diphenylfluorenyl, spirobifluorenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, biphenyl-substituted carbazolyl, benzonaphthofuranyl, benzonaphthothiophenyl;
preferably, ar is selected from
Figure BDA0003190395170000023
W is selected from O, S, NL 2 Ar 3 、CR 16 R 17
L 2 Selected from the group consisting of a linking bond, phenylene, naphthylene, biphenylene,
Ar 3 selected from phenyl, biphenyl, terphenyl, naphthyl, pyridyl, phenyl substituted naphthyl, naphthyl substituted phenyl, dibenzofuranyl, dibenzothiophenyl, dibenzofuran substituted phenyl, dibenzothiophenyl substituted phenyl, dimethylfluorenyl substituted phenyl, diphenylfluorenyl substituted phenyl, spirobifluorenyl,
R 4 、R 5 、R 6 、R 7 、R 8 、R 9 、R 10 、R 11 、R 12 、R 13 、R 14 、R 15 each independently selected from hydrogen, deuterium, phenyl and/or adjacent two thereof are connected to form a benzene ring,
R 16 、R 17 each independently selected from methyl, phenyl, or R 16 、R 17 The bonding is carried out to form a fluorenyl group,
and/or R 4 And R 11 Through a benzene ring or a naphthalene ring.
More preferably, ar is selected from the group consisting of substituted or unsubstituted:
Figure BDA0003190395170000031
Figure BDA0003190395170000041
Figure BDA0003190395170000051
wherein the wavy line represents the attachment site of the group.
Preferably, ar is selected from the group consisting of substituted or unsubstituted: phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, anthracenyl, phenanthrenyl, benzophenanthrenyl, pyridyl, dibenzofuranyl, dibenzothienyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, dimethylfluorenyl, diphenyl-substituted fluorenyl, spirobifluorenyl, benzonaphthofuranyl, benzonaphthothienyl, benzocarbazolyl, dibenzocarbazolyl, triazinyl, quinoxalinyl, quinazolyl, 2-phenylphenanthrene [3,4-d ] oxazolyl, 2-phenylphenanthrene [3,4-d ] thiazolyl.
Preferably, R n1 -R n8 、R m1 -R m6 Each independently selected from the group consisting of substituted or unsubstituted hydrogen, deuterium, phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, anthracenyl, phenanthrenyl, benzophenanthrenyl, pyridyl, dibenzofuranyl, dibenzothienyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, dimethylfluorenyl, diphenyl-substituted fluorenyl, spirobifluorenyl, benzonaphthofuranyl, benzonaphthothienyl, benzocarbazolyl, dibenzocarbazolyl, triazinyl, quinoxalinyl, 2-phenylphenanthrene [3,4-d ] phenyl]Oxazolyl, 2-phenylphenanthrene [3,4-d ]]A thiazolyl group.
Preferably, L is selected from the group consisting of a linker, phenylene, biphenylene, naphthylene, dibenzofuranylene.
When each group contains a substituent as described above, the substituents are independently selected from deuterium, halogen, cyano, unsubstituted or R ' substituted C1-C6 alkyl, unsubstituted or R ' substituted C6-C12 aryl, unsubstituted or R ' substituted C2-C20 heteroaryl;
r' is selected from deuterium, halogen, cyano, deuterium-substituted methyl and halogen-substituted methyl;
preferably, the aryl group is selected from phenyl, biphenyl, terphenyl, naphthyl, anthryl, phenanthryl, benzophenanthryl, naphthyl substituted phenyl, dimethylfluorenyl, diphenyl substituted fluorenyl, spirobifluorenyl,
preferably, the heteroaryl group is selected from pyridyl, dibenzofuranyl, dibenzothiophenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, benzonaphthofuranyl, benzonaphthothiophenyl, benzocarbazolyl, dibenzocarbazolyl,
preferably, the alkyl group is selected from methyl, ethyl, propyl, tert-butyl, cyclohexyl, adamantyl.
Preferably, the quinazoline structure-containing compound having the structure shown in formula (1-1) is any one of the following compounds:
Figure BDA0003190395170000061
Figure BDA0003190395170000071
Figure BDA0003190395170000081
Figure BDA0003190395170000091
Figure BDA0003190395170000101
Figure BDA0003190395170000111
Figure BDA0003190395170000121
Figure BDA0003190395170000131
Figure BDA0003190395170000141
Figure BDA0003190395170000151
preferably, the quinazoline structure-containing compound having the structure shown in formula (1-2) is any one of the following compounds:
Figure BDA0003190395170000152
Figure BDA0003190395170000161
Figure BDA0003190395170000171
Figure BDA0003190395170000181
Figure BDA0003190395170000191
Figure BDA0003190395170000201
Figure BDA0003190395170000211
in the present invention, the hole transport compound has a hole conducting property.
Preferably, the hole transport compound is a compound having a structure represented by formula (2):
Figure BDA0003190395170000212
wherein p is selected from the group consisting of integers from 0 to 4,
q is selected from the group consisting of integers from 0 to 4,
R 7 、R 8 each independently selected from the group consisting of substituted or unsubstituted C1-C30 alkyl, C1-C30 alkyl wherein one or more methylene groups are substituted by-O-or-S-in such a way that O atoms or S atoms are not adjacent substituted or unsubstituted C2-C30 alkenyl, C2-C30 alkenyl in which one or more methylene groups are substituted by-O-or-S-in such a manner that O atoms or S atoms are not adjacent, substituted or unsubstituted C2-C30 alkynyl substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxy, or substituted or unsubstituted C6-C30 aryloxy,
R 7 、R 8 each independently exists, or the adjacent two are connected by a chemical bond to form a ring B or R 7 、R 8 Connected with each other through a phenylene ring or a naphthylene ring;
L 2 、L 3 each independently selected fromA linkage, a substituted or unsubstituted C6-C30 arylene, a substituted or unsubstituted C2-C30 heteroarylene,
Ar 4 -Ar 7 each independently selected from substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl,
w1 is selected from the group consisting of integers from 0 to 1,
w2 is selected from the group consisting of integers from 0 to 1,
preferably, w1+ w2=1.
Preferably, the ring B is a substituted or unsubstituted group as follows: a benzene ring, a naphthalene ring, a benzothiophene ring, a benzofuran ring, an indene ring or an indole ring;
preferably, the hole transport compound is a compound having any one of the structures shown below:
Figure BDA0003190395170000221
preferably, R in formula (2) 7 、R 8 Are connected with adjacent ring substituents through phenylene to form a seven-membered fused ring,
preferably, the hole transporting compound is a compound having any one of the structures shown below (a compound having the seven-membered fused ring):
Figure BDA0003190395170000231
wherein q-2 is selected from 0, 1, 2.
Preferably, in the formula (2), L 2 、L 3 Each independently selected from the group consisting of a linking bond, a substituted or unsubstituted phenylene group, a substituted or unsubstituted biphenylene group, a substituted or unsubstituted naphthylene group, a substituted or unsubstituted dibenzofuran-substituted phenylene group, a substituted or unsubstituted dimethylfluorenyl-substituted phenylene group, a substituted or unsubstituted dibenzothiophene-substituted phenylene group, a substituted or unsubstituted terphenylene group, a substituted or unsubstituted dibenzofuranyl group, and a substituted or unsubstituted dimethylfluorenyl group;
preference is given toEarth, ar 4 -Ar 7 Each is independently selected from the following substituted or unsubstituted groups: phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, dibenzofuranyl, dibenzothiophenyl, dimethylfluorenyl, diphenylfluorenyl, spirobifluorenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, dibenzocarbazolyl, benzonaphthofuranyl, dinaphthofuranyl, benzonaphthothiophenyl, dinaphthothiophenyl;
R 7 、R 8 each independently selected from deuterium, halogen, cyano, substituted or unsubstituted groups as follows: methyl, ethyl, tert-butyl, adamantyl, phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, dibenzofuranyl, dibenzothiophenyl, dimethylfluorenyl, diphenylfluorenyl, spirobifluorenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, dibenzocarbazolyl, benzonaphthofuranyl, dinaphthofuranyl, benzonaphthothiophenyl, or dinaphthothiophenyl.
Preferably, when the groups defined in formula (1-1), formula (1-2) and formula (2) in the present invention carry a substituent, each of the substituents is independently selected from deuterium, halogen, cyano, unsubstituted or R ' substituted C1-C6 alkyl, unsubstituted or R ' substituted C6-C12 aryl, unsubstituted or R ' substituted C2-C20 heteroaryl; r' is selected from deuterium, halogen, cyano, deuterium-substituted methyl and halogen-substituted methyl.
Preferably, the aryl group is selected from phenyl, biphenyl, terphenyl, naphthyl, anthryl, phenanthryl, benzophenanthryl, naphthyl-substituted phenyl, dimethylfluorenyl, diphenyl-substituted fluorenyl or spirobifluorenyl;
preferably, the heteroaryl group is selected from pyridyl, dibenzofuranyl, dibenzothienyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, benzonaphthofuranyl, benzonaphthothienyl, benzocarbazolyl, or dibenzocarbazolyl;
preferably, the alkyl group is selected from methyl, ethyl, propyl, tert-butyl, cyclohexyl or adamantyl.
Preferably, the compound having the structure represented by formula (2) is any one of the following compounds:
Figure BDA0003190395170000241
Figure BDA0003190395170000251
Figure BDA0003190395170000261
Figure BDA0003190395170000271
Figure BDA0003190395170000281
Figure BDA0003190395170000291
Figure BDA0003190395170000301
preferably, the thermal decomposition temperature difference between the hole transport compound and the fused heterocyclic compound containing a quinazoline structure is less than 20 degrees centigrade (e.g. the thermal decomposition temperature difference is 18 degrees centigrade, 15 degrees centigrade, 13 degrees centigrade, 10 degrees centigrade, 8 degrees centigrade, 5 degrees centigrade, 3 degrees centigrade, etc.), or the LUMO energy level of the fused heterocyclic compound containing a quinazoline structure is deeper than-2.0 eV (e.g. can be-2.5 eV, -2.8eV, -3.0eV, -3.5eV, -4.0eV, etc.), and the HOMO energy level of the hole transport compound is shallower than-5.8 eV (e.g. -5.5eV, -5.0eV, -4.8eV, -4.5eV, -4eV, -3eV, etc.).
Preferably, the mass ratio of the fused heterocyclic compound containing a quinazoline structure to the hole-transporting compound is 1.
Preferably, the mass ratio of the fused heterocyclic compound containing a quinazoline structure to the hole transport type compound in the organic electroluminescent composition is 1.
Preferably, the mass ratio of the fused heterocyclic compound containing a quinazoline structure to the hole transport type compound in the organic electroluminescent composition is 2.
As used in the present invention, the term "halogen" may include fluorine, chlorine, bromine or iodine, preferably fluorine.
As used herein, the term "alkyl" refers to a monovalent substituent derived from a straight or branched chain saturated hydrocarbon having 1 to 30 carbon atoms, examples of which include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, and hexyl.
As used herein, unless otherwise specified, the term "cycloalkyl" refers to a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 30 carbon atoms. Examples of such cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, norbornyl, adamantane and the like.
Heteroaryl, heteroarylene groups of the invention include monocyclic, polycyclic or fused ring aryl groups, which rings may be interrupted by short non-aromatic units, including, but not limited to, furyl, thiophenyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, thiadiazolyl, isothiazolyl, isoxazolyl, oxazolyl, oxadiazolyl, triazinyl, tetrazinyl, triazolyl, tetrazolyl, furazanyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, benzofuranyl, benzothienyl, isobenzofuranyl, dibenzofuranyl, dibenzothienyl, benzimidazolyl, benzothiazolyl, benzisothiazolyl, benzisoxazolyl, benzoxazolyl, isoindolyl, indolyl, indazolyl, benzothiadiazolyl, quinolyl, isoquinolyl, cinnolinyl, quinazolinyl, quinoxalinyl, carbazolyl, phenazinyl, phenothiazinyl, phenanthrolinyl, benzodioxolyl, dihydroacridinyl, derivatives thereof, and the like.
Preferably, the aryl group is selected from phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, 9 '-dimethylfluorenyl, 9' -diphenylfluorenyl or spirobifluorenyl.
Preferably, the heteroaryl group is selected from dibenzofuranyl, dibenzothienyl, carbazolyl, triazinyl, pyridyl, pyrimidinyl, imidazolyl, oxazolyl, thiazolyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, naphthoimidazolyl, naphthooxazolyl, naphthothiazolyl, phenanthroimidazolyl, phenanthrooxazolyl, quinoxalinyl, quinazolinyl, indolocarbazolyl, indolofluorenyl, benzothiophenopyrazinyl, benzothiophenopyrimidyl, benzofuropyrazinyl, benzofuropyrimidinyl, indolopyrazinyl, indolopyrimidinyl, indenopyrazinyl, indenopyrimidinyl, spiro (fluorene-9, 1 '-indene) pyrazinyl, spiro (fluorene-9, 1' -indene) pyrimidinyl, benzofurocarbazolyl, or benzothiophenocarbazolyl.
As used herein, the term "aryloxy" refers to a monovalent substituent represented by RO-, wherein R represents an aryl group having 6 to 30 carbon atoms. Examples of such aryloxy groups include, but are not limited to, phenoxy, naphthoxy, diphenoxy, and the like.
As used herein, the term "substituted" means that the hydrogen atom in the compound is replaced with another substituent. The position is not limited to a specific position as long as hydrogen at the position can be substituted by a substituent. When two or more substituents are present, the two or more substituents may be the same or different.
As used herein, unless otherwise specified, hydrogen atoms include protium, deuterium, and tritium.
The phrase "two adjacent groups are linked to form a ring" as used herein means that 2 substituents at adjacent positions on the same or adjacent rings can pass throughChemical bonds are connected with each other to form a ring, and the invention does not limit the specific connecting ring mode (for example, by single bond connection, etc.)
Figure BDA0003190395170000311
Thickening and passing
Figure BDA0003190395170000312
Thickening and passing
Figure BDA0003190395170000313
Thickening and passing
Figure BDA0003190395170000314
Thickening and passing
Figure BDA0003190395170000315
Thickening; wherein
Figure BDA0003190395170000316
Indicating a thick and dense position) has the same meaning as when the same description is referred to below.
In the present invention, the definition of a group defines a range of carbon numbers, the number of carbon atoms of which is any integer within the defined range, such as a C6-C60 aryl group, and the number of carbon atoms representing an aryl group can be any integer within the range encompassed by 6-60, such as 6, 8, 10, 15, 20, 30, 35, 40, 45, 50, 55, 60, or the like.
In the invention, the preparation route of the compound containing the quinazoline structure is as follows:
the general formula of the synthesis of the compound with the structure shown in the formula (1-1)
Figure BDA0003190395170000317
When L is selected from the link, the third step takes the route of (2);
the general formula of the synthesis of the compound with the structure shown in the formula (1-2)
Figure BDA0003190395170000321
When L is selected from the group consisting of the linkages, the second step follows the path of (2).
The preparation route of the hole transport type compound in the present invention is as follows:
Figure BDA0003190395170000322
in another aspect, the present invention provides the use of an organic electroluminescent composition as described above for the manufacture of an optical device.
Preferably, the optical device comprises any one of an organic electroluminescent device, an organic field effect transistor, an organic thin film transistor, an organic light emitting transistor, an organic integrated circuit, an organic solar cell, an organic field quenching device, a light emitting electrochemical cell, an organic laser diode or an organic photoreceptor.
In another aspect, the present invention provides an organic electroluminescent device comprising an anode and a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising the organic electroluminescent composition as described above.
Preferably, the organic layer includes a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer, which are stacked in this order from the anode side to the cathode side.
Preferably, the material of the light-emitting layer comprises a host material and a guest material, the host material comprising the organic electroluminescent composition as described above; the thermal decomposition temperature difference between the fused heterocyclic compound containing the quinazoline structure and the hole transport type compound is not more than 20 ℃, preferably 10 ℃, and further preferably 5 ℃;
preferably, the guest material comprises a phosphorescent dopant comprising a complex comprising Ir or Pt.
In another aspect, the present invention provides an organic electroluminescent device comprising the organic electroluminescent device as described above.
Compared with the prior art, the invention has the following beneficial effects:
compared with a single-component luminescent main body material, the organic electroluminescent composition has stronger combination of electrons and holes, and is more beneficial to improving the luminescent efficiency and prolonging the service life of a device. The organic electroluminescent device has lower driving voltage (below 3.55V), higher current efficiency (above 24 Cd/A) and longer service life (above 433 h).
Detailed Description
The technical solution of the present invention is further described below by way of specific embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
Synthetic examples
Figure BDA0003190395170000331
1-B Synthesis, 50ml of two-neck round-bottom flask is taken and put into a stirrer and an upper reflux pipe, nitrogen is filled after drying, 1-A (1 mmol), bis (pinacolato) diboron (1.2 mmol), potassium acetate (2 mmol), 1, 4-dioxane (20 ml) are respectively added, nitrogen protection is carried out, 1-bis (diphenylphosphino) ferrocene ] palladium (II) dichloride (0.05 mmol) is added, reflux is carried out for 12 hours, and after the reaction is finished, the crude product is purified by column chromatography (ethyl acetate/n-hexane: volume ratio is 1/10) to obtain 1-B (0.11 g, yield is 47%).
Synthesis of 1-D: taking a 50ml double-neck round-bottom flask, putting a stirrer and an upper connecting reflux pipe, introducing nitrogen after drying, and respectively adding a compound 1-C (1 mmol), a compound 1-B (1 mmol) and potassium carbonate (K) 2 CO 3 1.5mmol, ethanol (3 ml), water (3 ml), toluene (15 ml) and tetrakis (triphenylphosphine) palladium (Pd (PPh) 3 ) 4 0.05 mmol), heating to 60 ℃ and reacting for 12 hours, cooling to room temperature after the reaction is finished, adding 20 ml of water for quenching, extracting with dichloromethane (3X 20 ml), adding magnesium sulfate to the obtained extract in sequence for drying, filtering and spin-drying, and obtaining crude extractThe product was purified by chromatography (ethyl acetate/n-hexane: 1/10 by volume) to give 1-D (0.15 g, 43% yield).
Synthesis of 1-F: a100-milliliter two-neck round-bottom flask is taken and placed with a stirrer and an upper reflux pipe, nitrogen is filled after drying, 1-D (1 mmol), carbazole (1 mmol), cesium carbonate (0.012 mol), tris (dibenzylideneacetone) dipalladium (Pd 2 (dba) 3, 0.05mmol) and 2-dicyclohexylphosphorus-2 ',4',6' -triisopropylbiphenyl (xphos, 0.055 mmol) are respectively added, then toluene is added, the mixture is refluxed for 24 hours, the reaction system is cooled to room temperature after reaction, the reaction system is filtered and concentrated, and the crude product is purified by chromatography (dichloromethane/n-hexane, 1/10 (volume ratio)) to obtain 1-F (0.38 g, 79% of yield).
Synthesis of Compound 1: taking a 50ml double-neck round-bottom flask, putting a stirrer and an upper reflux pipe, introducing nitrogen after drying, and respectively adding 1-F (1 mmol) and dichlorobis (tricyclohexylphosphine) palladium (PdCl) 2 (PCy 3 ) 2 0.05 mmol), pivalic acid (t-BuCO) 2 H,2 mmol), cesium carbonate (Cs) 2 CO 3 2 mmol) and dimethylacetamide (20 ml) at 120 ℃ for 10 hours, after completion of the reaction, cooled to room temperature, the reaction was concentrated, and the crude product was purified by chromatography (ethyl acetate/n-hexane: volume ratio 1/10), yielding 1 (0.27 g, 61% yield).
Elemental analysis: c 32 H 19 N 3 Theoretical value: c,86.27; h,4.30; n,9.43; measured value: c,86.32; h,4.28; n,9.40; HRMS (ESI) M/z (M +): theoretical values are as follows: 445.1579; measured value: 445.1584.
Figure BDA0003190395170000341
2-F Synthesis: the synthesis of 1-F was identical except that 2-C was used instead of carbazole to give 2-F (0.47 g, 77% yield).
Synthesis of Compound 2: synthesis of Compound 1 except substituting 2-F for 1-F gave Compound 2 (0.38 g, 67% yield).
Elemental analysis: c 42 H 23 N 3 Theoretical values are as follows: and C,88.55; h,4.07; n,7.38; measured value: c,88.59; h,4.05; n,7.36; HRMS (ESI) M/z (M +): theoretical values are as follows: 569.1892; measured value: 569.1898.
Figure BDA0003190395170000342
synthesis of 5-F: the synthesis of 1-F was identical except that 5-C was used instead of carbazole to give 5-F (0.49 g, 71% yield).
Synthesis of Compound 5: synthesis of Compound 1, except that 1-F was replaced with 5-F, gave Compound 5 (0.46 g, 70% yield).
Elemental analysis: c 48 H 28 N 4 Theoretical value: c,87.25; h,4.27; n,8.48; measured value: c,87.30; h,4.25; n,8.45; HRMS (ESI) M/z (M +): theoretical value: 660.2314; measured value: 660.2319.
Figure BDA0003190395170000343
synthesis of 7-F: the same synthesis as 1-D except that 1-D was used instead of 1-C, and 7-C was used instead of 1-B gave 7-F (0.42 g, 67% yield).
Synthesis of compound 7: synthesis of Compound 1 except substituting 7-F for 1-F gave Compound 7 (0.45 g, 76% yield).
Elemental analysis: c 44 H 27 N 3 Theoretical values are as follows: c,88.42; h,4.55; n,7.03; measured value: c,88.38; h,4.57; n,7.05; HRMS (ESI) M/z (M +): theoretical values are as follows: 597.2205; measured value: 597.2213.
Figure BDA0003190395170000351
synthesis of 8-C: the same as 1-D except that 8-A was used instead of 1-C, and 8-B was used instead of 1-B, gave 8-C (0.12 g, 35% yield).
Synthesis of 8-D: the synthesis of 1-D was identical except that 1-C was replaced with 8-C and 1-B was replaced with o-chlorophenylboronic acid to give 8-D (0.18 g, 48% yield).
Synthesis of 8-E: the same synthesis as 1-D except that 1-C was replaced with 8-D and 1-B was replaced with phenylboronic acid gave 8-E (0.24 g, 58% yield).
Synthesis of 8-F: synthesis of Compound 1, except that 1-F was replaced with 8-E, yielded 8-F (0.30 g, 77% yield).
Synthesis of 8-G: in a 50ml three-necked bottle, 8-F (1 mmol), dichloromethane (20 ml) and a solution of boron tribromide (2 mmol) in dichloromethane are added dropwise at 0 ℃, after the reaction is completed, the solvent is removed, and the crude product is purified by column chromatography (ethyl acetate/n-hexane, 1/10) to obtain 8-G (0.33G, 88% yield).
Synthesis of 8-H: taking a 50ml two-neck round-bottom flask, putting a stirrer, adding 8-G (1 mmol), dichloromethane (20 ml) and pyridine (6 mmol), cooling a reaction system to 0 ℃, and adding Tf 2 O (1.5 mmol), stirring at room temperature for 30 minutes, cooling to 0 ℃, adding 30 ml dichloromethane, 40 ml water, drying the organic phase over anhydrous magnesium sulfate, distilling under reduced pressure to remove the solvent, and isolating the crude product by column chromatography (ethyl acetate/n-hexane, 1/10) to obtain 8-H (0.45 g, 90% yield).
Synthesis of 8-J: taking a 50ml round-bottom double-neck bottle, putting a stirrer and an upper reflux pipe, adding the double pinacolyl diboron (1.5 mmol), the potassium acetate (2 mmol), protecting with nitrogen, and adding Pd (dppf) Cl 2 (0.05 mmol) and 8-H (1 mmol) are heated to 80 ℃ to react for 2 hours, water is added after the reaction is finished to quench, the system is extracted by ethyl acetate, an organic phase is dried by anhydrous magnesium sulfate to remove an organic solvent, and a crude product is separated by column chromatography (ethyl acetate/n-hexane, 1/10) to obtain 8-J (0.43 g, 89 percent of yield).
Figure BDA0003190395170000352
Synthesis of compound 8: taking a 50ml double-neck round-bottom flask, putting a stirrer and an upper connecting reflux pipe, introducing nitrogen after drying, and respectively adding a compound 8-J (1 mmol), a compound 8-K (1 mmol) and potassium carbonate (K) 2 CO 3 1.5mmol, ethanol (3 ml), water (3 ml), toluene (15 ml) and tetrakis (triphenylphosphine) palladium (Pd (PPh) 3 ) 4 0.05 mmol), heated to 60 ℃ and reacted for 12 hours, cooled to room temperature after completion of the reaction, quenched by addition of 20 ml of water, extracted with dichloromethane (3 × 20 ml), the resulting extract dried over magnesium sulfate, filtered and spun, and the crude product purified by chromatography (ethyl acetate/n-hexane: volume ratio 1/10), yield 8 (0.48 g, 86% yield).
Elemental analysis: c 40 H 24 N 4 Theoretical value: c,85.69; h,4.31; n,9.99; measured value: c,85.73; h,4.30; n,9.97; HRMS (ESI) M/z (M +): theoretical value: 560.2001; measured value: 560.2009.
Figure BDA0003190395170000361
synthesis of compound 9: the same synthesis as 8, except that 8-K was replaced with 9-K gave 9 (0.60 g, 85% yield).
Elemental analysis: c 50 H 33 N 5 Theoretical value: c,85.32; h,4.73; n,9.95; measured value: c,85.27; h,4.75; n,9.98; HRMS (ESI) M/z (M +): theoretical value: 703.2736; measured value: 703.2742.
Figure BDA0003190395170000362
synthesis of 12-F: the same synthesis as 1-D except that 1-D was used instead of 1-C,12-C was used instead of 1-B gave 12-F (0.56 g, 72% yield).
Synthesis of compound 12: synthesis of Compound 1 except substituting 12-F for 1-F gave Compound 12 (0.58 g, 79% yield). Elemental analysis: c 53 H 33 N 5 Theoretical values are as follows: c,86.04; h,4.50; n,9.47; measured value: c,85.98; h,4.52; n,9.50; HRMS (ESI) M/z (M +): theoretical values are as follows: 739.2736; measured value: 739.2744.
Figure BDA0003190395170000363
synthesis of 1' -C: the synthesis of 1-D was identical except that 1' -A was used instead of 1-C,1' -B was used instead of 1-B to give 1' -C (0.13 g, 40% yield).
Synthesis of 1' -E: the same synthesis as 1-F, except that 1' -C was used instead of 1-D and 1' -D was used instead of carbazole, gave 1' -E (0.55 g, 78% yield).
Synthesis of compound 1': synthesis of Compound 1, except that 1'-E was used instead of 1-F, gave Compound 1' (0.53 g, 81% yield). Elemental analysis: c 48 H 28 N 4 Theoretical value: c,87.25; h,4.27; n,8.48; measured value: c,87.30; h,4.25; n,8.45; HRMS (ESI) M/z (M +): theoretical value: 660.2314; measured value: 660.2309.
Figure BDA0003190395170000371
synthesis of 2' -E: the same synthesis as 1-F, except that 1' -C was used instead of 1-D and 2' -D was used instead of carbazole, gave 2' -E (0.53 g, 76% yield).
Synthesis of compound 2': compound 2 '(0.53 g, 80% yield) was obtained by substituting 2' -E for 1-F, which is a difference in the synthesis of Compound 1. Elemental analysis: c 48 H 28 N 4 Theoretical value: c,87.25; h,4.27; n,8.48; measured value: c,87.29; h,4.26; n,8.45; HRMS (ESI) M/z (M +): theoretical values are as follows: 660.2314; measured value: 660.2305.
Figure BDA0003190395170000372
synthesis of 3' -E: the synthesis of 1-F was identical except that 1' -C was used instead of 1-D and 3' -D was used instead of carbazole to give 3' -E (0.47 g, 77% yield).
Synthesis of compound 3': the synthesis of compound 1 was performed with the difference that 1-F was replaced with 3'-E to give compound 3' (0.47 g,yield 82%). Elemental analysis: c 40 H 21 N 3 S theoretical value: c,83.45; h,3.68; n,7.30; s,5.57; measured value: c,83.40; h,3.69; n,7.32; s,5.59; HRMS (ESI) M/z (M +): theoretical values are as follows: 575.1456; measured value: 575.1464.
Figure BDA0003190395170000373
synthesis of 4' -E: the same synthesis as 1-F, except that 1' -C was used instead of 1-D and 4' -D was used instead of carbazole, gave 4' -E (0.45 g, 78% yield).
Synthesis of compound 4': synthesis of Compound 1, except that 1-F was replaced with 4'-E, gave Compound 4' (0.44 g, 81% yield). Elemental analysis: c 40 H 21 N 3 Theoretical value: c,88.38; h,3.89; n,7.73; measured value: c,88.42; h,3.88; n,7.70; HRMS (ESI) M/z (M +): theoretical values are as follows: 543.1735; measured value: 543.1730.
Figure BDA0003190395170000381
synthesis of 5' -E: the same synthesis as 1-F, except that 1' -C was used instead of 1-D and 5' -D was used instead of carbazole, gave 5' -E (0.47 g, 76% yield).
Synthesis of compound 5': compound 5 '(0.47 g, 80% yield) was obtained by substituting 5' -E for 1-F, which is a difference in the synthesis of Compound 1. Elemental analysis: c 42 H 26 N 4 Theoretical value: c,85.98; h,4.47; n,9.55; measured value: c,86.03; h,4.45; n,9.52; HRMS (ESI) M/z (M +): theoretical values are as follows: 586.2157; measured value: 586.2165.
Figure BDA0003190395170000382
synthesis of 6' -D: the same synthesis as 1-D except that 1' -C was used instead of 1-C,6' -D instead of 1-B gave 6' -E (0.43 g, 71% yield).
Synthesis of compound 6': compound 6 '(0.45 g, 80% yield) was obtained by substituting 6' -E for 1-F, which is a difference in the synthesis of Compound 1. Elemental analysis: c 40 H 24 N 4 Theoretical value: c,85.69; h,4.31; n,9.99; measured value: c,85.75; h,4.29; n,9.96; HRMS (ESI) M/z (M +): theoretical values are as follows: 560.2001; measured value: 560.2010.
Figure BDA0003190395170000383
in a 100 ml three-necked flask, nitrogen gas was introduced, and the compound H1-A (0.01 mol), the compound H1-B (0.01 mol), sodium tert-butoxide (0.02 mol), tris (dibenzylideneacetone) dipalladium (0) (0.2 mmol), a 50% tri-tert-butylphosphine solution (0.8 mmol) and 50ml of toluene were added, followed by stirring under reflux. After cooling to 25 ℃ with ethyl acetate and H 2 O extracts the organic layer. The extracted organic layer was over MgSO 4 Dried and filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (DCM/hexane) and then recrystallization purification using DCM/acetone mixed solvent, thereby obtaining compound H1 (0.43 g, yield 72%).
Elemental analysis: c 45 H 34 N 2 Theoretical value: c,89.67; h,5.69; n,4.65; measured value: c,89.70; h,5.67; n,4.63; HRMS (ESI) M/z (M +): theoretical value: 602.2722; measured value: 602.2713.
Figure BDA0003190395170000391
the same as H1, except that H2-A was used instead of H1-A and H2-B was used instead of H1-B, to give H2 (0.62 g, 88% yield)
Elemental analysis: c 52 H 32 N 2 Theoretical value of O: c,89.12; h,4.60; n,4.00; measured value: c,89.08; h,4.62; n,4.02; HRMS (ESI) M/z (M +): theoretical values are as follows: 700.2515; measured value: 700.2521.
Figure BDA0003190395170000392
good synthesis with H1, except substituting H3-A for H1-A and H3-B for H1-B, gave H3 (0.48 g, 86% yield)
Elemental analysis: c 42 H 28 N 2 Theoretical values are as follows: c,89.97; h,5.03; n,5.00; measured value: c,90.00; h,5.01; n,4.99; HRMS (ESI) M/z (M +): theoretical value: 560.2252; measured value: 560.2259.
Figure BDA0003190395170000393
the same as H1, except that H4-A was used instead of H1-A and H4-B was used instead of H1-B, to give H4 (0.57 g, 89% yield)
Elemental analysis: c 48 H 38 N 2 Theoretical value: c,89.68; h,5.96; n,4.36; measured value: c,89.72; h,5.94; n,4.34; HRMS (ESI) M/z (M +): theoretical value: 642.3035; measured value: 642.3042.
Figure BDA0003190395170000394
good synthesis with H1, except substituting H5-A for H1-A and H5-B for H1-B, gave H5 (0.61 g, 83% yield)
Elemental analysis: c 52 H 32 N 2 The theoretical value of OS: c,85.22; h,4.40; n,3.82; s,4.37; measured value: c,85.19; h,4.41; n,3.83; s,4.39; HRMS (ESI) M/z (M +): theoretical value: 732.2235; measured value: 732.2242.
Figure BDA0003190395170000401
good synthesis as H1 except substituting H6-A for H1-A and H6-B for H1-B gave H6 (0.37 g, 81% yield)
Element classificationAnd (3) analysis: c 34 H 24 N 2 Theoretical value: c,88.67; h,5.25; n,6.08; measured value: c,88.71; h,5.23; n,6.06; HRMS (ESI) M/z (M +): theoretical value: 460.1939; measured value: 460.1946.
Figure BDA0003190395170000402
the same as H1, except that H2-A was used instead of H1-A and H7-B was used instead of H1-B, to give H7 (0.53 g, 80% yield)
Elemental analysis: c 50 H 32 N 2 Theoretical value: c,90.88; h,4.88; n,4.24; measured value: c,90.91; h,4.86; n,4.23; HRMS (ESI) M/z (M +): theoretical values are as follows: 660.2565; measured value: 660.2574.
Figure BDA0003190395170000403
the same as H1, except that H8-A was used instead of H1-A, and H8-B was used instead of H1-B, to give H8 (0.57 g, 87% yield)
Elemental analysis: c 48 H 32 N 2 Theoretical value of O: c,88.32; h,4.94; n,4.29; measured value: c,88.29; h,4.95; n,4.31; HRMS (ESI) M/z (M +): theoretical value: 652.2515; measured value: 652.2523.
Figure BDA0003190395170000404
the same as H1, except that H6-A was used instead of H1-A and H9-B was used instead of H1-B, to give H9 (0.49 g, 85% yield)
Elemental analysis: c 43 H 32 N 2 Theoretical value: c,89.55; h,5.59; n,4.86; measured value: c,89.51; h,5.61; n,4.88; HRMS (ESI) M/z (M +): theoretical value: 576.2565; measured value: 576.2575.
Figure BDA0003190395170000411
good synthesis with H1, except substituting H10-A for H1-A and H10-B for H1-B, gave H10 (0.46 g, 85% yield)
Elemental analysis: c 40 H 28 N 2 Theoretical values are as follows: c,89.52; h,5.26; n,5.22; measured value: c,89.48; h,5.28; n,5.24; HRMS (ESI) M/z (M +): theoretical value: 536.2252; measured value: 536.2247.
Figure BDA0003190395170000412
good Synthesis with H1, except that H3-A was used instead of H1-A, and H11-B was used instead of H1-B, to give H11 (0.51 g, 86% yield)
Elemental analysis: c 44 H 30 N 2 Theoretical value: c,90.07; h,5.15; n,4.77; measured value: c,90.10; h,5.14; n,4.76; HRMS (ESI) M/z (M +): theoretical value: 586.2409; measured value: 586.2416.
device embodiment
The OLED has the following layer structure: a base ((ITO) coated glass substrate)/Hole Injection Layer (HIL)/Hole Transport Layer (HTL)/emissive layer (EML)/Electron Transport Layer (ETL)/Electron Injection Layer (EIL), and finally a cathode.
The materials used are specified in table 1, and the materials required to make an OLED are as follows.
Figure BDA0003190395170000413
The preparation of the organic electroluminescent device comprises the following steps:
(1) Substrate cleaning: carrying out ultrasonic treatment on the ITO-coated glass substrate in an aqueous cleaning agent (the components and the concentration of the aqueous cleaning agent are less than or equal to 10wt% of glycol solvent and less than or equal to 1wt% of triethanolamine), washing in deionized water, and carrying out ultrasonic treatment in the following steps of: ultrasonic degreasing is carried out in an ethanol mixed solvent (volume ratio is 1.
(2) Evaporating an organic light-emitting functional layer:
placing the glass substrate with the anode layer in a vacuum chamber, and vacuumizing to 1 × 10 -6 To 2X 10 -4 Pa, performing vacuum evaporation on the anode layer film to form a PD as a hole injection layer, wherein the evaporation thickness is 5nm;
a hole transport layer is evaporated on the hole injection layer, and the thickness of the evaporated film is 80nm;
the luminescent layer is vapor-plated on the hole transport layer, and the specific preparation method comprises the following steps: carrying out vacuum evaporation on a luminescent host material and a guest material in a co-evaporation manner, wherein the total thickness of the evaporation is 30nm;
a layer of electron transport layer is vacuum evaporated on the luminescent layer, and the preparation method comprises the following steps: carrying out vacuum evaporation on Bphen and LiQ in a co-evaporation mode, wherein the total film thickness of evaporation is 30nm;
vacuum evaporating an electron injection layer on the electron transmission layer, wherein the total film thickness of the evaporation is 1nm;
and evaporating Mg and Ag on the electron injection layer, wherein the total thickness of the evaporated film is 80nm.
The parameters of the layers in the device, their materials and thicknesses, etc., are shown in table 1.
TABLE 1
Figure BDA0003190395170000421
Figure BDA0003190395170000431
Testing the performance of the device:
the instrument comprises: the characteristics of the device such as current, voltage, brightness, luminescence spectrum and the like are synchronously tested by adopting a PR 650 spectrum scanning luminance meter and a Keithley K2400 digital source meter system;
and (3) testing conditions: the current density is 10mA/cm 2 Room temperature.
And (3) life test: the time (in hours) was recorded when the device brightness dropped to 95% of the original brightness.
The device performance test results are shown in table 2:
TABLE 2
Figure BDA0003190395170000432
As can be seen from Table 2, the organic electroluminescent device of the present invention has a low driving voltage (below 3.55V), a high current efficiency (above 24 Cd/A) and a long lifetime (above 433 h).
The applicant states that the present invention is illustrated by the above examples of the organic electroluminescent composition and the application thereof, but the present invention is not limited to the above examples, i.e. it does not mean that the present invention must be implemented by relying on the above examples. It should be understood by those skilled in the art that any modifications of the present invention, equivalent substitutions of the raw materials of the product of the present invention, and the addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.

Claims (10)

1. An organic electroluminescent composition is characterized by comprising a fused heterocyclic compound containing a quinazoline structure and a hole transport type compound, wherein the fused heterocyclic compound containing the quinazoline structure is a compound with a structure shown as a formula (1-1) or a formula (1-2),
Figure FDA0003190395160000011
l is selected from a linkage, a substituted or unsubstituted C6-C30 arylene, a substituted or unsubstituted C5-C30 heteroarylene,
ar is selected from substituted or unsubstituted C6-C60 aryl, substituted or unsubstituted C5-C60 heteroaryl, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C6-C60 arylamine, substituted or unsubstituted C5-C60 heteroarylamine, substituted or unsubstituted C5-C60 arylheteroarylamine,
R 1 -R 3 each independently selected from hydrogenDeuterium, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxy, or substituted or unsubstituted C6-C30 aryloxy,
R n1 -R n8 、R m1 -R m6 each independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxy, or substituted or unsubstituted C6-C30 aryloxy.
2. The organic electroluminescent composition according to claim 1, wherein Ar is selected from the group consisting of carbazole-based groups:
Figure FDA0003190395160000012
R 4 -R 11 each independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, C1-C30 alkyl wherein one or more methylene groups are substituted by-O-or-S-in such a way that O atoms or S atoms are not adjacent substituted or unsubstituted C2-C30 alkenyl, C2-C30 alkenyl in which one or more methylene groups are substituted by-O-or-S-in such a manner that O atoms or S atoms are not adjacent, substituted or unsubstituted C2-C30 alkynyl substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxyA substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C60 arylamine group, a substituted or unsubstituted C5-C60 heteroarylamine group, a substituted or unsubstituted C5-C60 arylheteroarylamine group,
R 4 -R 11 each independently exists or the two adjacent are connected to form a ring A; and/or R 4 And R 11 Through a benzene ring or a naphthalene ring;
preferably, the ring a is a substituted or unsubstituted benzene ring, a substituted or unsubstituted naphthalene ring, a substituted or unsubstituted benzothiophene ring, a substituted or unsubstituted benzofuran ring, a substituted or unsubstituted indene ring, a substituted or unsubstituted indole ring, a substituted or unsubstituted benzindole ring, a substituted or unsubstituted naphthoindole ring;
preferably, R 4 -R 11 Any two adjacent of them are fused with benzene ring, and/or R 4 And R 11 Connected through benzene ring and naphthalene ring;
preferably, R 4 -R 11 Each is independently selected from the following substituted or unsubstituted groups: phenyl, carbazolyl, phenyl-substituted carbazolyl, biphenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, dibenzofuran-substituted carbazolyl, terphenyl-substituted carbazolyl;
preferably, R 4 -R 11 Either one of them is combined with
Figure FDA0003190395160000021
The connection is carried out by connecting the two parts,
L 1 selected from the group consisting of a linking bond, phenylene, naphthylene, biphenylene,
Ar 1 、Ar 2 each is independently selected from the following substituted or unsubstituted groups: phenyl, biphenyl, terphenyl, naphthyl, pyridyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, dibenzofuranyl, dibenzothiophenyl, dimethylfluorenyl, diphenylfluorenyl, spirobifluorenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, biphenyl-substituted carbazolyl, benzonaphthofuranyl, benzonaphthothiophenyl;
preferably, ar is selected from
Figure FDA0003190395160000022
W is selected from O, S, NL 2 Ar 3 、CR 16 R 17
L 2 Selected from the group consisting of a linking bond, phenylene, naphthylene, biphenylene,
Ar 3 selected from the group consisting of phenyl, biphenyl, terphenyl, naphthyl, pyridyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, dibenzofuranyl, dibenzothienyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, dimethylfluorenyl-substituted phenyl, diphenylfluorenyl-substituted phenyl, spirobifluorenyl,
R 4 、R 5 、R 6 、R 7 、R 8 、R 9 、R 10 、R 11 、R 12 、R 13 、R 14 、R 15 each independently selected from hydrogen, deuterium, phenyl and/or adjacent two are connected to form a benzene ring,
R 16 、R 17 each independently selected from methyl, phenyl, or R 16 、R 17 The bonding is carried out to form a fluorenyl group,
and/or R 4 And R 11 Through benzene ring or naphthalene ring;
more preferably, ar is selected from the group consisting of substituted or unsubstituted:
Figure FDA0003190395160000023
Figure FDA0003190395160000031
Figure FDA0003190395160000041
Figure FDA0003190395160000051
wherein the wavy line represents the attachment site of the group;
preferably, ar is selected from the group consisting of substituted or unsubstituted: phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, anthracenyl, phenanthrenyl, benzophenanthrenyl, pyridyl, dibenzofuranyl, dibenzothienyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, dimethylfluorenyl, diphenyl-substituted fluorenyl, spirobifluorenyl, benzonaphthofuranyl, benzonaphthothienyl, benzocarbazolyl, dibenzocarbazolyl, triazinyl, quinoxalinyl, quinazolinyl, 2-phenylphenanthrene [3,4-d ] oxazolyl, 2-phenylphenanthrene [3,4-d ] thiazolyl;
preferably, R n1 -R n8 、R m1 -R m6 Each independently selected from the group consisting of substituted or unsubstituted hydrogen, deuterium, phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, anthracenyl, phenanthrenyl, benzophenanthrenyl, pyridyl, dibenzofuranyl, dibenzothiophenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, dimethylfluorenyl, diphenyl-substituted fluorenyl, spirobifluorenyl, benzonaphthofuranyl, benzonaphthothienyl, benzocarbazolyl, dibenzocarbazolyl, triazinyl, quinoxalinyl, 2-phenylphenanthrene [3,4-d ] phenyl]Oxazolyl, 2-phenylphenanthrene [3,4-d ]]A thiazolyl group;
preferably, L is selected from a linker, phenylene, biphenylene, naphthylene, dibenzofuranylene;
preferably, the substituents are each independently selected from deuterium, halogen, cyano, unsubstituted or R ' substituted C1-C6 alkyl, unsubstituted or R ' substituted C6-C12 aryl, unsubstituted or R ' substituted C2-C20 heteroaryl;
r' is selected from deuterium, halogen, cyano, deuterium-substituted methyl and halogen-substituted methyl;
preferably, the aryl group is selected from phenyl, biphenyl, terphenyl, naphthyl, anthryl, phenanthryl, benzophenanthryl, naphthyl substituted phenyl, dimethylfluorenyl, diphenyl substituted fluorenyl, spirobifluorenyl,
preferably, the heteroaryl group is selected from pyridyl, dibenzofuranyl, dibenzothiophenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, benzonaphthofuranyl, benzonaphthothiophenyl, benzocarbazolyl, dibenzocarbazolyl,
preferably, the alkyl group is selected from methyl, ethyl, propyl, tert-butyl, cyclohexyl, adamantyl;
preferably, the quinazoline structure-containing compound having the structure shown in the formula (1-1) is any one of the following compounds:
Figure FDA0003190395160000052
Figure FDA0003190395160000061
Figure FDA0003190395160000071
Figure FDA0003190395160000081
Figure FDA0003190395160000091
Figure FDA0003190395160000101
Figure FDA0003190395160000111
Figure FDA0003190395160000121
Figure FDA0003190395160000131
Figure FDA0003190395160000141
preferably, the quinazoline structure-containing compound having the structure shown in formula (1-2) is any one of the following compounds:
Figure FDA0003190395160000151
Figure FDA0003190395160000161
Figure FDA0003190395160000171
Figure FDA0003190395160000181
Figure FDA0003190395160000191
Figure FDA0003190395160000201
Figure FDA0003190395160000211
3. the organic electroluminescent composition according to any one of claims 1 to 3, wherein the hole transport compound is a compound having a structure represented by formula (2):
Figure FDA0003190395160000212
wherein p is selected from the group consisting of integers from 0 to 4,
q is selected from the group consisting of integers from 0 to 4,
R 7 、R 8 each independently selected from the group consisting of substituted or unsubstituted C1-C30 alkyl, C1-C30 alkyl wherein one or more methylene groups are substituted by-O-or-S-in such a manner that O atoms or S atoms are not adjacent substituted or unsubstituted C2-C30 alkenyl, C2-C30 alkenyl in which one or more methylene groups are substituted by-O-or-S-in such a manner that O atom or S atom is not adjacent, substituted or unsubstituted C2-C30 alkynyl substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, substituted or unsubstituted C3-C30 heteroaralkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C3-C30 heterocycloalkyl, substituted or unsubstituted C3-C30 cycloalkenyl, substituted or unsubstituted C1-C30 alkoxy, or substituted or unsubstituted C6-C30 aryloxy,
R 7 、R 8 each independently exists, or the two adjacent compounds are connected by chemical bonds to form a ring B or R 7 、R 8 Connected with each other through a phenylene ring or a naphthylene ring;
L 2 、L 3 each independently selected from the group consisting of a bond, substituted or unsubstituted C6-C30 arylene, substituted or unsubstituted C2-C30 heteroarylene,
Ar 4 -Ar 7 each independently selected from substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl,
w1 is selected from the group consisting of integers from 0 to 1,
w2 is selected from the group consisting of integers from 0 to 1,
preferably, w1+ w2=1.
4. The organic electroluminescent composition according to any one of claims 1 to 3, wherein the ring B is a substituted or unsubstituted group selected from the group consisting of: a benzene ring, a naphthalene ring, a benzothiophene ring, a benzofuran ring, an indene ring or an indole ring;
preferably, the hole transport compound is a compound having any one of the structures shown below:
Figure FDA0003190395160000221
preferably, R in formula (2) 7 、R 8 Are connected with adjacent ring substituents through phenylene to form a seven-membered fused ring,
preferably, the hole transport compound is a compound having any one of the structures shown below (a compound having the seven-membered fused ring):
Figure FDA0003190395160000231
wherein q-2 is selected from 0, 1, 2;
preferably, in the formula (2), L 2 、L 3 Each independently selected from the group consisting of a linking bond, a substituted or unsubstituted phenylene group, a substituted or unsubstituted biphenylene group, a substituted or unsubstituted naphthylene group, a substituted or unsubstituted dibenzofuran-substituted phenylene group, a substituted or unsubstituted dimethylfluorenyl-substituted phenylene group, a substituted or unsubstituted phenylene groupSubstituted dibenzothiophene substituted phenylene, substituted or unsubstituted terphenylene, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dimethylfluorenyl;
preferably, ar 4 -Ar 7 Each is independently selected from the following substituted or unsubstituted groups: phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, dibenzofuranyl, dibenzothiophenyl, dimethylfluorenyl, diphenylfluorenyl, spirobifluorenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, dibenzocarbazolyl, benzonaphthofuranyl, dinaphthofuranyl, benzonaphthothiophenyl, dinaphthothiophenyl;
R 7 、R 8 each independently selected from deuterium, halogen, cyano, substituted or unsubstituted groups as follows: methyl, ethyl, tert-butyl, adamantyl, phenyl, biphenyl, terphenyl, naphthyl, phenyl-substituted naphthyl, naphthyl-substituted phenyl, dibenzofuranyl, dibenzothienyl, dimethylfluorenyl, diphenylfluorenyl, spirobifluorenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, dibenzocarbazolyl, benzonaphthofuranyl, dinaphthofuranyl, benzonaphthothienyl or dinaphthothiophenyl;
preferably, when the groups defined in formula (1-1), formula (1-2) and formula (2) carry substituents, each of said substituents is independently selected from deuterium, halogen, cyano, unsubstituted or R ' substituted C1-C6 alkyl, unsubstituted or R ' substituted C6-C12 aryl, unsubstituted or R ' substituted C2-C20 heteroaryl; r' is selected from deuterium, halogen, cyano, deuterium-substituted methyl and halogen-substituted methyl;
preferably, the aryl group is selected from phenyl, biphenyl, terphenyl, naphthyl, anthryl, phenanthryl, benzophenanthryl, naphthyl-substituted phenyl, dimethylfluorenyl, diphenyl-substituted fluorenyl or spirobifluorenyl;
preferably, the heteroaryl group is selected from pyridyl, dibenzofuranyl, dibenzothiophenyl, carbazolyl, phenyl-substituted carbazolyl, pyridyl-substituted carbazolyl, naphthyl-substituted carbazolyl, biphenyl-substituted carbazolyl, dibenzofuran-substituted phenyl, dibenzothiophene-substituted phenyl, benzonaphthofuranyl, benzonaphthothiophenyl, benzocarbazolyl, or dibenzocarbazolyl;
preferably, the alkyl group is selected from methyl, ethyl, propyl, tert-butyl, cyclohexyl or adamantyl.
5. The organic electroluminescent composition according to any one of claims 1 to 4, wherein the compound having the structure represented by formula (2) is any one of the following compounds:
Figure FDA0003190395160000241
Figure FDA0003190395160000251
Figure FDA0003190395160000261
Figure FDA0003190395160000271
Figure FDA0003190395160000281
Figure FDA0003190395160000291
Figure FDA0003190395160000301
6. the organic electroluminescent composition according to any one of claims 1 to 5, wherein the difference between the thermal decomposition temperatures of the hole-transporting compound and the fused heterocyclic compound containing the quinazoline structure is less than 20 ℃, or the LUMO energy level of the fused heterocyclic compound containing the quinazoline structure is deeper than-2.0 eV, and the HOMO energy level of the hole-transporting compound is shallower than-5.8 eV.
7. The organic electroluminescent composition according to any one of claims 1 to 6, wherein the mass ratio of the fused heterocyclic compound containing a quinazoline structure to the hole transport compound in the organic electroluminescent composition is 1.
8. Use of an organic electroluminescent composition according to any one of claims 1 to 7 for the preparation of an optical device;
preferably, the optical device comprises any one of an organic electroluminescent device, an organic field effect transistor, an organic thin film transistor, an organic light emitting transistor, an organic integrated circuit, an organic solar cell, an organic field quenching device, a light emitting electrochemical cell, an organic laser diode or an organic photoreceptor.
9. An organic electroluminescent device comprising an anode and a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising the organic electroluminescent composition according to any one of claims 1 to 7;
preferably, the organic layer includes a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer, which are stacked in this order from the anode side to the cathode side;
preferably, the material of the light-emitting layer comprises a host material and a guest material, the host material comprising the organic electroluminescent composition according to any one of claims 1 to 7; the thermal decomposition temperature difference between the fused heterocyclic compound containing the quinazoline structure and the hole transport type compound is not more than 20 ℃, preferably 10 ℃, and further preferably 5 ℃;
preferably, the guest material comprises a phosphorescent dopant comprising a complex comprising Ir or Pt.
10. An organic electroluminescent device, characterized in that the organic electroluminescent device comprises the organic electroluminescent device as claimed in claim 9.
CN202110875588.5A 2021-07-30 2021-07-30 Organic electroluminescent composition and application thereof Pending CN115700269A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110875588.5A CN115700269A (en) 2021-07-30 2021-07-30 Organic electroluminescent composition and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110875588.5A CN115700269A (en) 2021-07-30 2021-07-30 Organic electroluminescent composition and application thereof

Publications (1)

Publication Number Publication Date
CN115700269A true CN115700269A (en) 2023-02-07

Family

ID=85120810

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110875588.5A Pending CN115700269A (en) 2021-07-30 2021-07-30 Organic electroluminescent composition and application thereof

Country Status (1)

Country Link
CN (1) CN115700269A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140026783A (en) * 2012-08-23 2014-03-06 주식회사 두산 Organic light-emitting compound and organic electroluminescent device using the same
CN107556310A (en) * 2017-09-20 2018-01-09 石家庄诚志永华显示材料有限公司 Imdazole derivatives, material and organic electroluminescence device comprising the imdazole derivatives
CN109232377A (en) * 2018-09-30 2019-01-18 长春海谱润斯科技有限公司 A kind of aromatic amino-derivative and its organic electroluminescence device
CN109456203A (en) * 2018-11-03 2019-03-12 长春海谱润斯科技有限公司 A kind of triarylamine derivative and its organic electroluminescence device
CN112939946A (en) * 2019-12-10 2021-06-11 北京鼎材科技有限公司 Compound and application thereof
CN113121364A (en) * 2019-12-31 2021-07-16 陕西莱特光电材料股份有限公司 Nitrogen-containing compound, organic electroluminescent device, and electronic device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140026783A (en) * 2012-08-23 2014-03-06 주식회사 두산 Organic light-emitting compound and organic electroluminescent device using the same
CN107556310A (en) * 2017-09-20 2018-01-09 石家庄诚志永华显示材料有限公司 Imdazole derivatives, material and organic electroluminescence device comprising the imdazole derivatives
CN109232377A (en) * 2018-09-30 2019-01-18 长春海谱润斯科技有限公司 A kind of aromatic amino-derivative and its organic electroluminescence device
CN109456203A (en) * 2018-11-03 2019-03-12 长春海谱润斯科技有限公司 A kind of triarylamine derivative and its organic electroluminescence device
CN112939946A (en) * 2019-12-10 2021-06-11 北京鼎材科技有限公司 Compound and application thereof
CN113121364A (en) * 2019-12-31 2021-07-16 陕西莱特光电材料股份有限公司 Nitrogen-containing compound, organic electroluminescent device, and electronic device

Similar Documents

Publication Publication Date Title
KR102613323B1 (en) Heterocyclic compound and organic light emitting device comprising the same
EP3683217A1 (en) Heterocyclic compound and organic light emitting element comprising same
EP4190779A1 (en) Heterocyclic compound, organic light-emitting device comprising same, and composition for organic layer of organic light-emitting device
KR20220047661A (en) Nitrogen-containing compound, electronic device and electronic device comprising same
TWI637953B (en) Hetero-cyclic compound and organic light emitting device using the same
KR102589217B1 (en) Hetero-cyclic compound and organic light emitting device using the same
EP4201931A1 (en) Heterocyclic compound and organic light-emitting device comprising same
JP2022532949A (en) Nitrogen-containing compounds, electronic components and electronic devices
JP2022504349A (en) Organic electroluminescent compounds and organic electroluminescent devices containing them
CN114773286B (en) Nitrogen-containing heterocyclic organic compound and organic light-emitting device thereof
JP2021158350A (en) Multiple host materials and organic electroluminescent device comprising the same
KR102143580B1 (en) Organic light emitting device, manufacturing method of the same and composition for organic layer of organic light emitting device
CN114805179A (en) Nitrogen-containing compound, organic electroluminescent device, and electronic device
CN116261347A (en) Organic electroluminescent device
CN113227084A (en) Compound, composition, organic photoelectric device and display device
JP2022517639A (en) Organic electroluminescent compounds and organic electroluminescent devices containing them
CN116143739A (en) Diamine compound and organic light-emitting device thereof
KR102559828B1 (en) Compound and organic light emitting device using the same
JP2022022206A (en) Organic electroluminescent compound, plural host materials, and organic electroluminescent device using the same
JP2023500759A (en) Heterocyclic compound, organic light-emitting device containing the same, composition for organic layer of organic light-emitting device, and method for manufacturing organic light-emitting device
CN115700269A (en) Organic electroluminescent composition and application thereof
KR102589223B1 (en) Hetero-cyclic compound and organic light emitting device using the same
JP2022519189A (en) Compounds, organic optoelectronic devices and display devices
CN115700247B (en) Compound containing quinazoline structure and application thereof
CN114497424B (en) Organic electroluminescent device and electronic device including the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination